MDOI Convergence Chronicles 110.0553/CON.2026.00527
110.0553/CON.2026.00527
Article

A Value Set for EQ-5D-5L in the United Arab Emirates

Fatima Al Sayah, PhD, Bram Roudijk, PhD, Mohamed El Sadig, PhD, Asma Al Mannaei, MD, Mohamad N. Farghaly, MD, Sara Dallal, MD, Rima Kaddoura, PhD, Mirna Metni, PharmD, Iffat Elbarazi, DrPH, Samer A. Kharroubi, PhD 2025 Convergence Chronicles

Abstract

Objectives This study aimed to develop a value set for the EQ-5D-5L based on preferences of the general adult population of the United Arab Emirates (UAE). Methods The study followed the EuroQol EQ-5D-5L valuation protocol and involved conducting interviewer-administered face-to-face or online interviews in Arabic or English, using the EuroQol Valuation Technology with a sample of 1005 adults representing the UAE general population. Sample recruitment involved a 2-stage quota sampling strategy across the 7 emirates of the UAE, ensuring representation of nationals and expatriates. Various models using composite time trade-off data only, discrete choice experiment data only, and hybrid using both composite time trade-off and discrete choice experiment data were examined, along with various sensitivity analyses to examine the robustness of the models. Results The average age of respondents was 39 years (SD 10.8), 44.5% were female, and 11% were UAE nationals. The best-performing model to generate the value set for the EQ-5D-5L was the hybrid tobit model censored at −1.0, corrected for heteroskedasticity. Values ranged from −0.654 for the worst health state (55555) to 1 for full health (11111) and 0.962 for 11211, with 15.3% of predicted values worse than dead. Mobility problems had the largest impact on health state preference values relative to other dimensions. Conclusion This value set will facilitate the application and use of the EQ-5D-5L instrument in the UAE population in generating local evidence on the cost-effectiveness of healthcare interventions, as well as to enhance other applications of EQ-5D in population health assessment and health systems.

Identifier Metadata

Identifier 110.0553/CON.2026.00527
Canonical mdoi:110.0553/CON.2026.00527
Resolver URL https://mdoi.org/110.0553/CON.2026.00527
Resource URL Open resource
Document URL Open document
Content Type Article
Authors Fatima Al Sayah, PhD, Bram Roudijk, PhD, Mohamed El Sadig, PhD, Asma Al Mannaei, MD, Mohamad N. Farghaly, MD, Sara Dallal, MD, Rima Kaddoura, PhD, Mirna Metni, PharmD, Iffat Elbarazi, DrPH, Samer A. Kharroubi, PhD
Year 2025
Depositor Convergence Chronicles Organisation
Prefix 110.0553
Registered July 9, 2026
Updated July 9, 2026
Status Active
Visibility Public

Cite This Identifier

APA 7th Edition

Click to copy

MLA 9th Edition

Click to copy

Chicago 17th Edition

Click to copy

BibTeX

Click to copy

Persistent Identifier

mdoi:110.0553/CON.2026.00527

Click to copy

About MDOI

MDOI identifiers are permanent and unique identifiers assigned to digital objects to ensure long-term access, tracking, and referencing.

  • MDOI provides a permanent identity for digital objects.
  • Each MDOI is unique and points to one specific resource.
  • The prefix, such as 110.XXXX, identifies the registrant.
  • The suffix identifies the exact digital object.
  • MDOI remains stable even when a website URL changes.
  • It helps prevent broken links in digital publishing.
  • It makes academic and digital resources easier to find and cite.
  • MDOI supports proper tracking and management of digital content.
  • It improves the credibility and visibility of published resources.
  • MDOI ensures digital objects remain accessible, traceable, and reliable over time.
CO
Registered by Convergence Chronicles